Skip to content

Clinical Research on the Treatment of Functional Constipation with Dragon-Tiger Combat Acupuncture and Multimodal Brain Functional Imaging Analysis

Clinical Research on the Treatment of Functional Constipation with Dragon-Tiger Combat Acupuncture and Multimodal Brain Functional Imaging Analysis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000330
Enrollment
Unknown
Registered
2025-02-18
Start date
2024-12-20
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional constipation

Interventions

Experimental Group:Treatment with Dragon Tiger Clash Acupuncture Technique

Sponsors

The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meets the above-mentioned diagnostic criteria of Western medicine and the diagnostic criteria of Yin deficiency and dry intestines syndrome in traditional Chinese medicine; (2) Age within 40-70 years old gender not limited; (3) At least one week has passed since the last intake of drugs related to this disease or other treatment methods and no other ongoing clinical research has been participated in; (4) Signed the informed consent form and the patient voluntarily participates in the trial.

Exclusion criteria

Exclusion criteria: (1) Not meeting the diagnostic criteria for the syndrome of Yin deficiency and dry intestines in this study as defined by both traditional Chinese and Western medicine; (2) Those with organic lesions in the rectum and colon (such as tumors Crohn's disease colonic polyps intestinal tuberculosis etc.) causing intestinal stenosis confirmed by examination; (3) Irritable bowel syndrome and constipation caused by organic or drug-related factors; secondary constipation due to endocrine metabolic neurological or surgical conditions; (4) Those with severe primary diseases such as cardiovascular liver kidney and hematopoietic system diseases mental disorders etc. that cannot tolerate constipation treatment; (5) Pregnant or lactating women or those planning to conceive; (6) Those who have received other treatments or taken related medications within one week; (7) Those who are unwilling to participate in the trial sign the informed consent form or cannot comply with the trial requirements.

Design outcomes

Primary

MeasureTime frame
Cleveland Clinic Score;

Secondary

MeasureTime frame
Self-rating Anxiety Scale;Bristol Stool Form Scale;Self-rating Depression Scale;Patient Assessmentof Constipation Quality of Life questionnaire;

Countries

China

Contacts

Public ContactJia Hongling

The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine

jiahl1969@163.com18254178199

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026